-+ 0.00%
-+ 0.00%
-+ 0.00%

Kazia Therapeutics launches tranched registered public offering of ADSs, warrants

PUBT·08/27/2026 20:10:57
Listen to the news
Kazia Therapeutics launches tranched registered public offering of ADSs, warrants
  • Kazia launched a tranched registered public offering of ADSs or pre-funded warrants, paired with Series A and Series B warrants.
  • Each ADS represents 500 ordinary shares.
  • Series A warrants priced at 115% of the offering price, expiring 30 days after Stage IV TNBC data or five years.
  • Series B warrants priced at 125% of the offering price, expiring 30 days after HR+/HER2- data or five years.
  • Proceeds earmarked for paxalisib development, including TNBC and HR+/HER2- breast cancer studies, working capital, general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kazia Therapeutics Limited published the original content used to generate this news brief via CNW (Ref. ID: 202608271609CANADANWCANADAPR_C9447) on August 27, 2026, and is solely responsible for the information contained therein.